Karl Kramer

2.9k total citations
38 papers, 1.1k citations indexed

About

Karl Kramer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Karl Kramer has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Biotechnology. Recurrent topics in Karl Kramer's work include Monoclonal and Polyclonal Antibodies Research (22 papers), Protein purification and stability (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Karl Kramer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (22 papers), Protein purification and stability (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Karl Kramer collaborates with scholars based in Germany, United States and United Kingdom. Karl Kramer's co-authors include Bertold Hock, Siegfried Scherer, Martin J. Loessner, Frank Ebel, Bernhard Küster, Monika Seifert, Zhixiang Wu, Guillaume Médard, Thomas Giersch and Simone Lemeer and has published in prestigious journals such as Environmental Science & Technology, Nature Biotechnology and Analytical Chemistry.

In The Last Decade

Karl Kramer

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Kramer Germany 20 663 273 255 153 129 38 1.1k
Mirna Mujacic United States 11 1.1k 1.7× 225 0.8× 138 0.5× 170 1.1× 37 0.3× 13 1.5k
Eliana De Bernardez Clark United States 10 1.3k 2.0× 290 1.1× 72 0.3× 90 0.6× 105 0.8× 11 1.6k
Harald Seitz Germany 21 1.4k 2.1× 119 0.4× 292 1.1× 199 1.3× 72 0.6× 49 1.9k
Grish C. Varshney India 22 1.2k 1.8× 227 0.8× 52 0.2× 175 1.1× 60 0.5× 42 1.7k
Asif Shajahan United States 17 650 1.0× 135 0.5× 162 0.6× 113 0.7× 34 0.3× 37 1.2k
James F. Kane United States 19 1.5k 2.2× 167 0.6× 241 0.9× 63 0.4× 79 0.6× 47 1.8k
Christopher H. Taron United States 23 1.3k 1.9× 214 0.8× 69 0.3× 189 1.2× 68 0.5× 55 1.6k
Mark S. Stoll United Kingdom 28 1.6k 2.4× 297 1.1× 53 0.2× 50 0.3× 36 0.3× 46 2.2k
Anja Resemann Germany 15 875 1.3× 201 0.7× 52 0.2× 74 0.5× 52 0.4× 22 1.4k

Countries citing papers authored by Karl Kramer

Since Specialization
Citations

This map shows the geographic impact of Karl Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Kramer more than expected).

Fields of papers citing papers by Karl Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Kramer. The network helps show where Karl Kramer may publish in the future.

Co-authorship network of co-authors of Karl Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Kramer. A scholar is included among the top collaborators of Karl Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Kramer. Karl Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kramer, Karl, Julian Müller, Severin Lechner, et al.. (2024). Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics. Nature Biotechnology. 43(3). 406–415. 11 indexed citations
2.
Frejno, Martin, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.. (2017). Pharmacoproteomic characterisation of human colon and rectal cancer. Molecular Systems Biology. 13(11). 951–951. 35 indexed citations
3.
Koch, Heiner, M. Estela del Castillo Busto, Karl Kramer, Guillaume Médard, & Bernhard Küster. (2015). Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition. Journal of Proteome Research. 14(6). 2617–2625. 40 indexed citations
4.
Lemeer, Simone, et al.. (2011). Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. Journal of Proteomics. 75(12). 3465–3477. 51 indexed citations
5.
Wu, Zhixiang, Jessica Doondeea, Amin Moghaddas Gholami, et al.. (2011). Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer. Molecular & Cellular Proteomics. 10(12). M111.011635–M111.011635. 57 indexed citations
6.
González‐Techera, Andrés, et al.. (2005). Analyte Peptidomimetics Selected from Phage Display Peptide Libraries:  A Systematic Strategy for the Development of Environmental Immunoassays. Environmental Science & Technology. 39(11). 4234–4241. 25 indexed citations
7.
Kramer, Karl & Bertold Hock. (2003). Recombinant antibodies for environmental analysis. Analytical and Bioanalytical Chemistry. 377(3). 417–426. 34 indexed citations
8.
Iqbal, Muhammad Zafar, et al.. (2002). DEVELOPMENT OF ELISA TECHNIQUE FOR THE ANALYSIS OF ATRAZINE RESIDUES IN WATER. Journal of Environmental Science and Health Part B. 37(4). 307–322. 10 indexed citations
9.
Rau, Doris, Karl Kramer, & Bertold Hock. (2002). Cloning, functional expression and kinetic characterization of pesticide-selective F ab fragment variants derived by molecular evolution of variable antibody genes. Analytical and Bioanalytical Chemistry. 372(2). 261–267. 11 indexed citations
10.
Loessner, Martin J., Karl Kramer, Frank Ebel, & Siegfried Scherer. (2002). C‐terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high‐affinity binding to bacterial cell wall carbohydrates. Molecular Microbiology. 44(2). 335–349. 288 indexed citations
11.
12.
Kramer, Karl. (2002). Synthesis of a group-selective antibody library against haptens. Journal of Immunological Methods. 266(1-2). 209–220. 14 indexed citations
13.
Rau, Doris, Karl Kramer, & Bertold Hock. (2002). SINGLE-CHAIN FvANTIBODY-ALKALINE PHOSPHATASE FUSION PROTEINS PRODUCED BY ONE-STEP CLONING AS RAPID DETECTION TOOLS FOR ELISA. Journal of Immunoassay and Immunochemistry. 23(2). 129–143. 25 indexed citations
14.
Hock, Bertold, Monika Seifert, & Karl Kramer. (2002). Engineering receptors and antibodies for biosensors. Biosensors and Bioelectronics. 17(3). 239–249. 68 indexed citations
15.
Kramer, Karl, et al.. (2001). Long-Term Monitoring of Atrazine Contamination in Soil by ELISA. Journal of AOAC International. 84(1). 150–155. 12 indexed citations
16.
Piehler, Jacob, Andreas Brecht, Thomas Giersch, et al.. (1997). Affinity characterization of monoclonal and recombinant antibodies for multianalyte detection with an optical transducer. Sensors and Actuators B Chemical. 39(1-3). 432–437. 11 indexed citations
17.
Kramer, Karl & Bertold Hock. (1996). Recombinant single‐chain antibodies againsts‐Triazines. Food and Agricultural Immunology. 8(2). 97–109. 32 indexed citations
18.
Hock, Bertold, et al.. (1995). Immunochemical techniques: Antibody production for pesticide analysis. A review. Analytica Chimica Acta. 311(3). 393–405. 46 indexed citations
19.
Giersch, Thomas, Karl Kramer, & Bertold Hock. (1993). Optimization of a monoclonal antibody-based enzyme immunoassay for the detection of terbuthylazine. The Science of The Total Environment. 132(2-3). 435–448. 19 indexed citations
20.
Giersch, Thomas, Karl Kramer, Michael G. Weller, & Bertold Hock. (1993). Improvement of a Monoclonal Antibody‐based Immunoassay for the Determination of Terbutryn Verbesserung eines Immunassays mit monoklonalen Antikörpern zur Bestimmung von Terbutryn. Acta hydrochimica et hydrobiologica. 21(6). 312–315. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirna Mujacic Breakdown of academic impact, for papers by Eliana De Bernardez Clark Breakdown of academic impact, for papers by Harald Seitz Breakdown of academic impact, for papers by Grish C. Varshney Breakdown of academic impact, for papers by Asif Shajahan Breakdown of academic impact, for papers by James F. Kane Breakdown of academic impact, for papers by Christopher H. Taron Breakdown of academic impact, for papers by Mark S. Stoll Breakdown of academic impact, for papers by Anja Resemann
Rankless by CCL
2026